Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Hug

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|April 24, 2023
Treatment With Erythropoietin for Patients With Optic Neuritis: Long-term Follow-upSebastian Küchlin, Gabriele Ihorst, Birgit Grotejohann, et al.
International Journal of Molecular Sciences|March 27, 2025
Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10Charlotte Gutzler, Kerstin Höhne, Daniele Bani, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2007
Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronineMarc Slawik, Björn Klawitter, Edith Meiser, et al.
Brain Communications|April 20, 2026
Treatment of optic neuritis with erythropoietin: impact on white matter and optic nerve MRI characteristicsSebastian Küchlin, Niklas Lützen, Navid Farassat, et al.
The Lancet. Neurology|November 20, 2021
Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled studyWolf A Lagrèze, Sebastian Küchlin, Gabriele Ihorst, et al.
Journal of Cancer Research and Clinical Oncology|January 24, 2022
Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myelomaJohannes M Waldschmidt, Stefan J Fruttiger, Dagmar Wider, et al.
Applied Health Economics and Health Policy|September 26, 2023
Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase PricesAniek Dane, Anne-Sophie Klein Gebbink, Jan-Dietert Brugma, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
Falsified Medicines Directive in a Secondary Care Environment-Impact on Supply ChainPiotr Merks, Urszula Religioni, Nuno Pinto de Castro, et al.
Frontiers in Pharmacology|March 25, 2026
Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European regionJulie Vancoppenolle, Nora Franzen, Cristina Andrianò, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 21, 2021
Biosensor-Enabled Multiplexed On-Site Therapeutic Drug Monitoring of AntibioticsH Ceren Ates, Hasti Mohsenin, Christin Wenzel, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Neurology(R) Neuroimmunology & Neuroinflammation|April 24, 2023
Treatment With Erythropoietin for Patients With Optic Neuritis: Long-term Follow-upSebastian Küchlin, Gabriele Ihorst, Birgit Grotejohann, et al.
International Journal of Molecular Sciences|March 27, 2025
Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10Charlotte Gutzler, Kerstin Höhne, Daniele Bani, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2007
Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronineMarc Slawik, Björn Klawitter, Edith Meiser, et al.
Brain Communications|April 20, 2026
Treatment of optic neuritis with erythropoietin: impact on white matter and optic nerve MRI characteristicsSebastian Küchlin, Niklas Lützen, Navid Farassat, et al.
The Lancet. Neurology|November 20, 2021
Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled studyWolf A Lagrèze, Sebastian Küchlin, Gabriele Ihorst, et al.
Journal of Cancer Research and Clinical Oncology|January 24, 2022
Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myelomaJohannes M Waldschmidt, Stefan J Fruttiger, Dagmar Wider, et al.
Applied Health Economics and Health Policy|September 26, 2023
Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase PricesAniek Dane, Anne-Sophie Klein Gebbink, Jan-Dietert Brugma, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
Falsified Medicines Directive in a Secondary Care Environment-Impact on Supply ChainPiotr Merks, Urszula Religioni, Nuno Pinto de Castro, et al.
Frontiers in Pharmacology|March 25, 2026
Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European regionJulie Vancoppenolle, Nora Franzen, Cristina Andrianò, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 21, 2021
Biosensor-Enabled Multiplexed On-Site Therapeutic Drug Monitoring of AntibioticsH Ceren Ates, Hasti Mohsenin, Christin Wenzel, et al.
Pageof 5